These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 10330184)
1. Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice. Smith KS; Rhee JW; Naumovski L; Cleary ML Mol Cell Biol; 1999 Jun; 19(6):4443-51. PubMed ID: 10330184 [TBL] [Abstract][Full Text] [Related]
2. Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia. Honda H; Inaba T; Suzuki T; Oda H; Ebihara Y; Tsuiji K; Nakahata T; Ishikawa T; Yazaki Y; Hirai H Blood; 1999 May; 93(9):2780-90. PubMed ID: 10216071 [TBL] [Abstract][Full Text] [Related]
3. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF. Inukai T; Inaba T; Ikushima S; Look AT Mol Cell Biol; 1998 Oct; 18(10):6035-43. PubMed ID: 9742120 [TBL] [Abstract][Full Text] [Related]
4. Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2. Smith KS; Rhee JW; Cleary ML Mol Cell Biol; 2002 Nov; 22(21):7678-87. PubMed ID: 12370314 [TBL] [Abstract][Full Text] [Related]
5. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties. Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829 [TBL] [Abstract][Full Text] [Related]
6. Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice. Duque-Afonso J; Smith KS; Cleary ML PLoS One; 2015; 10(11):e0143216. PubMed ID: 26588248 [TBL] [Abstract][Full Text] [Related]
8. Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia. Yamasaki N; Miyazaki K; Nagamachi A; Koller R; Oda H; Miyazaki M; Sasaki T; Honda ZI; Wolff L; Inaba T; Honda H Oncogene; 2010 Apr; 29(13):1963-75. PubMed ID: 20062079 [TBL] [Abstract][Full Text] [Related]
9. E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF. Yoshihara T; Inaba T; Shapiro LH; Kato JY; Look AT Mol Cell Biol; 1995 Jun; 15(6):3247-55. PubMed ID: 7760820 [TBL] [Abstract][Full Text] [Related]
10. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF. Hunger SP; Brown R; Cleary ML Mol Cell Biol; 1994 Sep; 14(9):5986-96. PubMed ID: 8065331 [TBL] [Abstract][Full Text] [Related]
11. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein. Inaba T; Shapiro LH; Funabiki T; Sinclair AE; Jones BG; Ashmun RA; Look AT Mol Cell Biol; 1994 May; 14(5):3403-13. PubMed ID: 8164688 [TBL] [Abstract][Full Text] [Related]
12. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors. de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044 [TBL] [Abstract][Full Text] [Related]